This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ginsberg, J. Articles by Brindley, D. N. Search for Related Content PubMed PubMed Citation Articles by Ginsberg, J. Articles by Brindley, D. N.

Activation of Phospholipase D in FRTL-5 Thyroid Cells by Forskolin and Dibutyryl-Cyclic Adenosine Monophosphate¹

Signal Transduction Laboratories, Departments of Medicine (J.G., W.C.M., S.G.), Biochemistry (D.N.B.), and Oral Health Sciences (L.K.), University of Alberta, Edmonton, Alberta, Canada

Address all correspondence and requests for reprints to: J. Ginsberg, Division of Endocrinology, Department of Medicine, 362 Heritage Medical Research Center, University of Alberta, Edmonton, Alberta T6G 2S2 Canada. E-mail: Jody.Ginsberg{at}UAlberta.Ca

We demonstrated previously that TSH activates phospholipase D (PLD) via stimulation of protein kinase C (PKC) in Fischer rat thyroid line (FRTL)-5 thyroid cells. To examine the role of the cAMP pathway in the regulation of PLD, we studied the effects of forskolin (0–100 µM; 30 min) and dibutyryl cAMP (dbcAMP;0–1 mM; 30 min) on PLD activation. FRTL-5 thyroid cells were labeled mainly in phosphatidylcholine with [³H]myristate followed by incubation with 200 mM ethanol before the addition of agonist. PLD was assessed by the measurement of [³H]phosphatidylethanol. Forskolin (100 nM to 100 µM) and dbcAMP (100 pM to 100 µM) increased PLD activity significantly. Maximal responses to forskolin and dbcAMP exceed the PLD responses produced by 100 µU/ml of TSH. To determine whether the effects of forskolin and dbcAMP on PLD occurred as a consequence of PKC activation, FRTL-5 thyroid cells were preincubated for 10 min with the PKC inhibitors, chelerythrine (1 µM) or calphostin C (1 µM), or they were pretreated for 24 h with phorbol myristate acetate (100 nM) to down-regulate PKC. Unlike TSH-mediated PLD activation, these treatments had no effect on PLD activation by cAMP agonists. Forskolin (10 µM; 30 min) had no effect on the subcellular distribution of PKC -, -, or -isoforms, confirming the lack of involvement of PKC. The protein kinase A (PKA) inhibitors, H-89 (10 µM; 30 min) and dideoxyadenosine (5 nM;10 min) significantly decreased the forskolin- and dbcAMP-mediated PLD activation without any effect on the phorbol ester-mediated PLD response. Following pretreatment with H-89 or dideoxyadenosine, the TSH-mediated PLD response was also significantly reduced. These studies indicate that forskolin and dbcAMP stimulate PLD in FRTL-5 thyroid cells directly via PKA without involvement of PKC. Studies of cells in the presence and absence of ethanol revealed approximately 60% of the phosphatidate plus diacylglycerol produced via TSH occurs via PLD activation. Although TSH-mediated inositol phosphate generation occurred with similar concentrations of TSH that led to PLD activation, 10-fold higher TSH concentrations were required to increase intracellular Ca²⁺. These results and the lack of a rapid Ca²⁺ transient following physiological TSH concentrations suggest that alternatives to conventional hydrolysis of phosphatidylinositol 4,5-bisphosphate may initiate PKC activation. Thus, the two major signal transduction systems in the FRTL-5 thyroid cell (PKA and PKC) appear to converge on PLD activation. Stimulation of both of these pathways by TSH may be required for optimal physiological activation of PLD.

This article has been cited by other articles:

				M. A Frias, F. Dubouloz, M. C Rebsamen, and U. Lang Prostacyclin production in rat aortic smooth muscle cells: role of protein kinase C, phospholipase D and cyclooxygenase-2 expression Cardiovasc Res, November 1, 2003; 60(2): 438 - 446. [Abstract] [Full Text] [PDF]

				N. Thibault, C. Burelout, D. Harbour, P. Borgeat, P. H. Naccache, and S. G. Bourgoin Occupancy of adenosine A2a receptors promotes fMLP-induced cyclic AMP accumulation in human neutrophils: impact on phospholipase D activity and recruitment of small GTPases to membranes J. Leukoc. Biol., February 1, 2002; 71(2): 367 - 377. [Abstract] [Full Text] [PDF]

				H. Le Stunff, L. Dokhac, and S. Harbon The Roles of Protein Kinase C and Tyrosine Kinases in Mediating Endothelin-1-Stimulated Phospholipase D Activity in Rat Myometrium: Differential Inhibition by Ceramides and Cyclic AMP J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 629 - 637. [Abstract] [Full Text]

				A. M. Mamoon, J. Smith, R. C. Baker, and J. M. Farley Activation of Protein Kinase A Increases Phospholipase D Activity and Inhibits Phospholipase D Activation by Acetylcholine in Tracheal Smooth Muscle J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1188 - 1195. [Abstract] [Full Text]

				X. Li, S. Lu, E. Miyagi, R. Katoh, and A. Kawaoi Thyrotropin Prevents Apoptosis by Promoting Cell Adhesion and Cell Cycle Progression in FRTL-5 Cells Endocrinology, December 1, 1999; 140(12): 5962 - 5970. [Abstract] [Full Text]